Literature DB >> 19375632

Cryptococcosis: an emerging respiratory mycosis.

Shaunna M Huston1, Christopher H Mody.   

Abstract

Cryptococcosis occurs in immunocompromised and, in special cases, immunocompetent individuals. There have been a number of important advances in the field, but, despite current treatment, patients continue to die of the infection. This article reviews cryptococcosis epidemiology, clinical features, and management. Current knowledge is incomplete, however, so this article also discusses some of the gaps in the present understanding of cryptococcosis. The hope is that current research striving to understand the mechanisms of host evasion of Cryptococcus will result in improved treatment regimens that decrease both the mortality and morbidity of cryptococcosis.

Entities:  

Mesh:

Year:  2009        PMID: 19375632     DOI: 10.1016/j.ccm.2009.02.006

Source DB:  PubMed          Journal:  Clin Chest Med        ISSN: 0272-5231            Impact factor:   2.878


  14 in total

Review 1.  Adaptation of Cryptococcus neoformans to mammalian hosts: integrated regulation of metabolism and virulence.

Authors:  Jim Kronstad; Sanjay Saikia; Erik David Nielson; Matthias Kretschmer; Wonhee Jung; Guanggan Hu; Jennifer M H Geddes; Emma J Griffiths; Jaehyuk Choi; Brigitte Cadieux; Mélissa Caza; Rodgoun Attarian
Journal:  Eukaryot Cell       Date:  2011-12-02

Review 2.  Histopathologic diagnosis of fungal infections in the 21st century.

Authors:  Jeannette Guarner; Mary E Brandt
Journal:  Clin Microbiol Rev       Date:  2011-04       Impact factor: 26.132

3.  Retrospective analysis of 76 immunocompetent patients with primary pulmonary cryptococcosis.

Authors:  Feng Ye; Jia-xing Xie; Qing-si Zeng; Guo-qin Chen; Shu-qing Zhong; Nan-shan Zhong
Journal:  Lung       Date:  2012-01-14       Impact factor: 2.584

4.  Heterocycle Thiazole Compounds Exhibit Antifungal Activity through Increase in the Production of Reactive Oxygen Species in the Cryptococcus neoformans-Cryptococcus gattii Species Complex.

Authors:  Nívea Pereira de Sá; Caroline Miranda de Lima; Cleudiomar Inácio Lino; Paulo Jorge Sanches Barbeira; Ludmila de Matos Baltazar; Daniel Assis Santos; Renata Barbosa de Oliveira; Eleftherios Mylonakis; Beth Burgwyn Fuchs; Susana Johann
Journal:  Antimicrob Agents Chemother       Date:  2017-07-25       Impact factor: 5.191

5.  The RGS protein Crg2 is required for establishment and progression of murine pulmonary cryptococcosis.

Authors:  Amy Whittington; Ping Wang
Journal:  Med Mycol       Date:  2010-09-06       Impact factor: 4.076

6.  The Mediterranean red alga Asparagopsis: a source of compounds against Leishmania.

Authors:  Giuseppa Genovese; Laura Tedone; Mark T Hamann; Marina Morabito
Journal:  Mar Drugs       Date:  2009-08-11       Impact factor: 5.118

7.  Disseminated cryptococcosis initially presenting as cellulitis in a patient suffering from nephrotic syndrome.

Authors:  Wentao Ni; Qi Huang; Junchang Cui
Journal:  BMC Nephrol       Date:  2013-01-22       Impact factor: 2.388

8.  Pathogenic diversity amongst serotype C VGIII and VGIV Cryptococcus gattii isolates.

Authors:  Jéssica Rodrigues; Fernanda L Fonseca; Rafael O Schneider; Rodrigo M da C Godinho; Carolina Firacative; Krystyna Maszewska; Wieland Meyer; Augusto Schrank; Charley Staats; Livia Kmetzsch; Marilene H Vainstein; Marcio L Rodrigues
Journal:  Sci Rep       Date:  2015-07-08       Impact factor: 4.379

9.  Central nervous system and Cryptococcus neoformans.

Authors:  Veronica A Gaona-Flores
Journal:  N Am J Med Sci       Date:  2013-08

10.  Identification of the major molecular types of Cryptococcus neoformans and C. gattii by Hyperbranched rolling circle amplification.

Authors:  Luciana Trilles; Bin Wang; Carolina Firacative; Márcia Dos Santos Lazéra; Bodo Wanke; Wieland Meyer
Journal:  PLoS One       Date:  2014-04-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.